0.193
price down icon8.23%   -0.0173
after-market Handel nachbörslich: .20 0.007 +3.63%
loading

Finanzdaten der Processa Pharmaceuticals Inc-Aktie (PCSA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Operating Income/Loss
38.77%
-3.9508
-2.847 -2.7347 -3.4249 -3.082
Income/Loss From Continuing Operations Before Tax
38.79%
-3.9339
-2.8344 -2.7287 -3.3847 -3.0103
Income/Loss From Continuing Operations After Tax
38.79%
-3.9339
-2.8344 -2.7287 -3.3847 -3.0103
Net Income/Loss
38.79%
-3.9339
-2.8344 -2.7287 -3.3847 -3.0103
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
63.43%
15.57
9.5268 0.15 3.276 2.9833
Diluted Average Shares
63.43%
15.57
9.5268 0.15 3.276 2.9833
Basic Earnings Per Share
16.67%
-0.25
-0.30 -0.74 -1.03 -1.01
Diluted Earnings Per Share
16.67%
-0.25
-0.30 -0.74 -1.03 -1.01
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$34.90
price down icon 2.43%
$81.66
price down icon 2.97%
$28.84
price down icon 2.07%
$98.08
price down icon 1.67%
$135.59
price down icon 3.84%
biotechnology ONC
$328.71
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):